-
Ceramides Drive RGNNV Replication via Autophagy
2026-09-07
The reference study uses global lipidomics and targeted pathway perturbation to show that red-spotted grouper nervous necrosis virus (RGNNV) increases ceramide production and exploits ceramide-dependent autophagy for replication. Its rescue experiments with C16-ceramide identify sphingolipid metabolism as a mechanistically actionable host factor, while also defining important limits for transfer to other cell and disease models.
-
Firefly Luciferase mRNA Workflow Guide
2026-09-07
Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA designed for durable translation and reduced innate immune recognition. This guide connects practical transfection optimization with sex-aware interpretation of preclinical mRNA-LNP studies.
-
Hoechst 33342 for Live-Cell Nuclear Assays
2026-09-05
Hoechst 33342 combines rapid live-cell nuclear labeling with a compact blue-fluorescence workflow for chromatin visualization, cell cycle analysis, and apoptosis-oriented imaging. Its greatest practical value in transport studies is as a nuclear landmark that complements, rather than replaces, cargo labeling and force measurements.
-
Fluorouracil in Cancer Research: Practical Workflows
2026-09-04
Build reproducible 5-Fluorouracil assays around thymidylate synthase inhibition, DNA-replication stress, and orthogonal phenotypic readouts. This workflow also shows how the SMC2/SMC4 breast cancer findings can guide biomarker-stratified sensitivity experiments without overstating translational evidence.
-
RSL3 Workflow for Ferroptosis Research
2026-09-04
Build more decisive ferroptosis assays with RSL3, a direct GPX4 perturbation tool for redox-sensitive cancer models and mechanistic validation. This workflow also shows how RSL3 can complement nerve-injury studies by separating lipid-peroxidation causality from antioxidant rescue.
-
MVC, RhoA/ROCK1 Signaling, and Tight Junction Entry
2026-09-03
Ren et al. show that Minute Virus of Canines (MVC) VP2 interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, remodeling tight junctions and exposing Occludin during infection. The study provides a mechanistic framework for understanding MVC entry and for testing pathway-directed interventions, while its conclusions remain primarily grounded in a canine cell-culture model.
-
Sabutoclax Workflows for Apoptosis Assays
2026-09-03
Sabutoclax supports mechanism-aware cancer assays that separate growth inhibition from true cell killing. This workflow combines pan-Bcl-2 pathway coverage, orthogonal apoptosis readouts, and genotype-aware controls to improve interpretation in cell and xenograft studies.
-
Amorolfine Hydrochloride and Fungal Cell Limits
2026-09-02
A translational perspective on how Amorolfine Hydrochloride can help researchers connect fungal membrane biosynthesis, ploidy-associated stress, assay design, and antifungal resistance studies.
-
Rotigotine: From Receptor Signal to PD Assay
2026-09-02
Rotigotine is more than a dopamine D2/D3 receptor agonist: it is a versatile probe for connecting receptor pharmacology, exposure design, and neuroprotective phenotypes. This guide translates continuous dopaminergic delivery concepts into rigorous Parkinson’s disease research assays.
-
From Reporter Signal to Smarter mRNA Delivery
2026-09-01
Firefly Luciferase mRNA can function as more than a bright endpoint: it can help translational teams resolve how capping, nucleoside modification, poly(A) architecture, and delivery vehicles shape expression, persistence, and immune context.
-
MVC Entry via RhoA/ROCK1/MLC2 Signaling
2026-09-01
The reference study identifies a previously unreported interaction between MVC VP2 and the kinase domain of ROCK1 and links this interaction to RhoA/ROCK1/MLC2-driven tight-junction disruption. Its experiments support Occludin as a potential co-receptor and show that pathway inhibition can reduce MVC-associated barrier permeability, viral protein expression, and genomic copy number in canine cells.
-
Firefly Luciferase mRNA: Workflow & Optimization
2026-08-31
Build cleaner mRNA delivery experiments with a Cap1-capped, 5-moUTP-modified luciferase transcript designed for strong, sustained reporter expression. Use it to compare transfection systems, evaluate organ-selective lipid nanoparticles, and separate delivery failure from translation or cell-health effects.
-
Sex Differences in Ang II Hypertension in Mice
2026-08-31
This study used conscious-mouse telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Its findings connect sex-dependent blood pressure regulation with altered baroreflex control and a stronger sympathetic contribution in male mice, providing a useful framework for mechanistic hypertension research.
-
IR-820 (New Indocyanine Green) Imaging Workflows
2026-08-30
IR-820 supports quantitative near-infrared fluorescence imaging across vascular mapping, tumor localization, and diseased tissue measurement. This workflow-focused guide separates validated study insights from practical pilot conditions so researchers can optimize signal, controls, and longitudinal readouts without overinterpreting therapeutic nanomedicine data.
-
Cy3 RNA Labeling Kit: Practical Workflow Guide
2026-08-29
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research applications such as in situ hybridization and Northern blot hybridization, not for diagnostic, clinical, or therapeutic use.